The store will not work correctly when cookies are disabled.
1-Benzoyl-5-nitro-1H-indazole-3-carboxylic Acid Methyl Ester
ID: ALA2409451
PubChem CID: 71818688
Max Phase: Preclinical
Molecular Formula: C16H11N3O5
Molecular Weight: 325.28
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COC(=O)c1nn(C(=O)c2ccccc2)c2ccc([N+](=O)[O-])cc12
Standard InChI: InChI=1S/C16H11N3O5/c1-24-16(21)14-12-9-11(19(22)23)7-8-13(12)18(17-14)15(20)10-5-3-2-4-6-10/h2-9H,1H3
Standard InChI Key: DGCKICNEBFFWGE-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
3.6347 -3.5907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6335 -4.4102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3416 -4.8192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3398 -3.1818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0484 -3.5871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0487 -4.4102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8299 -4.6671 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3153 -3.9983 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8309 -3.3331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8163 -5.4827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1012 -5.8783 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.5164 -5.9042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4993 -6.7199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1986 -7.1413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9146 -6.7456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9269 -5.9243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2270 -5.5066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2052 -2.6066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0214 -2.5676 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.4634 -3.2550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7632 -1.9193 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9262 -3.1825 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.2185 -3.5912 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9260 -2.3653 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
7 10 1 0
10 11 2 0
10 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
9 18 1 0
18 19 1 0
19 20 1 0
18 21 2 0
22 23 2 0
22 24 1 0
1 22 1 0
M CHG 2 22 1 24 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 325.28 | Molecular Weight (Monoisotopic): 325.0699 | AlogP: 2.42 | #Rotatable Bonds: 3 |
Polar Surface Area: 104.33 | Molecular Species: NEUTRAL | HBA: 7 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.60 | CX LogD: 2.60 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.42 | Np Likeness Score: -1.34 |
References
1. Crocetti L, Schepetkin IA, Cilibrizzi A, Graziano A, Vergelli C, Giomi D, Khlebnikov AI, Quinn MT, Giovannoni MP.. (2013) Optimization of N-benzoylindazole derivatives as inhibitors of human neutrophil elastase., 56 (15): [PMID:23844670] [10.1021/jm400742j] |